<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8018594" created="13/07/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8018594</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Effects of <term id="T1" lex="prostaglandin_E2" sem="Lipid">prostaglandin E2</term> on <term id="T2" lex="Th0-type_human_T_cell_clone" sem="Cell_cultured">Th0-type human T cell clones</term>: modulation of functions of <term id="T3" lex="nuclear_protein" sem="Protein_family_or_group">nuclear proteins</term> involved in <term id="T4" lex="cytokine_production" sem="Other"><term id="T5" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term>.</sentence>
<event id="E1">
<type class="Regulation"/>
<cause idref="T1"/>
<clue><clueType>Effects</clueType> <linkCause>of</linkCause> prostaglandin E2 <clueLoc>on Th0-type human T cell clones</clueLoc>: modulation of functions of nuclear proteins involved in cytokine production.</clue>
<comment>NER T1 MOD</comment></event>
<event id="E2">
<type class="Regulation"/>
<theme idref="T3"/>
<cause idref="T1"/>
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: <clueType>modulation</clueType> <linkTheme>of</linkTheme> functions of nuclear proteins involved in cytokine production.</clue>
</event>
<event id="E3">
<type class="Gene_expression"/>
<theme idref="T5"/>
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine <clueType>production</clueType>.</clue>
</event>
<event id="E4">
<type class="Correlation"/>
<theme idref="T3"/>
<theme idref="E3"/>
<clue>Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins <clueType>involved</clueType> <linkTheme>in</linkTheme> cytokine production.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The effects of <term id="T6" lex="prostaglandin_E2" sem="Lipid">prostaglandin E2</term> (<term id="T7" lex="PGE2" sem="Lipid">PGE2</term>) on <term id="T8" lex="cytokine_production" sem="Other"><term id="T9" lex="cytokine" sem="Protein_family_or_group">cytokine</term> production</term> and <term id="T10" lex="proliferation" sem="Other">proliferation</term> of the <term id="T11" lex="CD4+_human_helper_T_cell_clone_SP-B21" sem="Cell_cultured">CD4+ human helper T cell clone SP-B21</term> were investigated.</sentence>
<event KT="Other" id="E5">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>The effects of prostaglandin E2 (PGE2) on cytokine <clueType>production</clueType> and proliferation of the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
<comment>NER T6,T7 MOD</comment></event>
<event KT="Investigation" id="E6" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="T7"/>
<clue>The <clueType>effects</clueType> <linkCause>of</linkCause> prostaglandin E2 (PGE2) <linkTheme>on</linkTheme> cytokine production and proliferation of the CD4+ human helper T cell clone SP-B21 were <clueKT>investigated</clueKT>.</clue>
</event>
<event KT="Other" id="E7">
<type class="Cellular_physiological_process"/>
<theme idref="T11"/>
<clue>The effects of prostaglandin E2 (PGE2) on cytokine production and <clueType>proliferation</clueType> <linkTheme>of</linkTheme> the CD4+ human helper T cell clone SP-B21 were investigated.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>The <clueType>effects</clueType> <linkCause>of</linkCause> prostaglandin E2 (PGE2) <linkTheme>on</linkTheme> cytokine production and proliferation of the CD4+ human helper T cell clone SP-B21 were <clueKT>investigated</clueKT>.</clue>
</event>
<sentence id="S3">In <term id="A1" sem="Cell_natural">cells</term> stimulated with <term id="T12" lex="anti-CD3_mAb" sem="Protein_molecule">anti-CD3 mAb</term>, <term id="T13" lex="PGE2" sem="Lipid">PGE2</term> inhibited <term id="T14" lex="cell_proliferation" sem="Other">cell proliferation</term> and the production of all the <term id="T15" lex="cytokine" sem="Protein_family_or_group">cytokines</term> examined.</sentence>
<event id="E9">
<type class="Negative_regulation"/>
<theme idref="T14"/>
<cause idref="T13"/>
<clue><clueLoc>In cells stimulated with anti-CD3 mAb</clueLoc>, PGE2 <clueType>inhibited</clueType> cell proliferation and the production of all the cytokines examined.</clue>
<comment>NER T13 MOD</comment></event>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>In cells stimulated with anti-CD3 mAb, PGE2 inhibited cell proliferation and the <clueType>production</clueType> <linkTheme>of</linkTheme> all the cytokines examined.</clue>
</event>
<event id="E11">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="T13"/>
<clue><clueLoc>In cells stimulated with anti-CD3 mAb</clueLoc>, PGE2 <clueType>inhibited</clueType> cell proliferation and the production of all the cytokines examined.</clue>
</event>
<event KT="Method" id="E12">
<type class="Physiological_process"/>
<theme idref="A1"/>
<cause idref="T12"/>
<clue>In cells <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb, PGE2 inhibited cell proliferation and the production of all the cytokines examined.</clue>
</event>
<sentence id="S4">Addition of <term id="T16" lex="rIL-2" sem="Protein_molecule">rIL-2</term> fully restored the proliferative response and partially restored the production of <term id="T17" lex="IL-4" sem="Protein_molecule">IL-4</term> and <term id="T18" lex="IL-5" sem="Protein_molecule">IL-5</term>, but not that of <term id="T19" lex="cytokine" sem="Protein_family_or_group">other cytokines</term>.</sentence>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T16"/>
<clue><linkCause>Addition of</linkCause> rIL-2 fully <clueType>restored</clueType> <corefTheme>the proliferative response</corefTheme> and partially restored the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E15">
<type class="Gene_expression"/>
<theme idref="T17"/>
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E16">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event KT="Other" id="E17">
<type class="Gene_expression"/>
<theme idref="T19"/>
<clue>Addition of rIL-2 fully restored the proliferative response and partially restored the <clueType>production</clueType> of IL-4 and IL-5, but not that <linkTheme>of</linkTheme> other cytokines.</clue>
<comment>NER T19 MOD, CAUTION: that = production</comment></event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T16"/>
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T16"/>
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but not that of other cytokines.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T16"/>
<clue><linkCause>Addition of</linkCause> rIL-2 fully restored the proliferative response and partially <clueType>restored</clueType> the production of IL-4 and IL-5, but <cluePolarity>not</cluePolarity> that of other cytokines.</clue>
</event>
<sentence id="S5">In contrast, in <term id="A2" sem="Cell_natural">cells</term> stimulated with <term id="T20" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> (<term id="T22" lex="PMA" sem="Organic_compound_other">PMA</term>)/<term id="T23" lex="A23187" sem="Organic_compound_other">A23187</term>, <term id="T24" lex="PGE2" sem="Lipid">PGE2</term> enhanced the production of <term id="T25" lex="IL-4" sem="Protein_molecule">IL-4</term> and <term id="T26" lex="IL-5" sem="Protein_molecule">IL-5</term>, and only partially inhibited the production of <term id="T27" lex="cytokine" sem="Protein_family_or_group">other cytokines</term>.</sentence>
<event KT="Method" id="E21">
<type class="Physiological_process"/>
<theme idref="A2"/>
<cause idref="T22"/>
<cause idref="T23"/>
<clue>In contrast, in cells <clueType>stimulated</clueType> <linkCause>with</linkCause> phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
<comment>NER T24 MOD, T21 DEL</comment></event>
<event id="E22">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E23">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the <clueType>production</clueType> <linkTheme>of</linkTheme> IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T24"/>
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 <clueType>enhanced</clueType> the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T24"/>
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 <clueType>enhanced</clueType> the production of IL-4 and IL-5, and only partially inhibited the production of other cytokines.</clue>
</event>
<event id="E26">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>In contrast, in cells stimulated with phorbol myristate acetate (PMA)/A23187, PGE2 enhanced the production of IL-4 and IL-5, and only partially inhibited the <clueType>production</clueType> of other cytokines.</clue>
<comment>NER T27 MOD</comment></event>
<event Manner="Low" id="E27">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T24"/>
<clue>In contrast, <clueLoc>in cells stimulated with phorbol myristate acetate (PMA)/A23187</clueLoc>, PGE2 enhanced the production of IL-4 and IL-5, and only <clueManner>partially</clueManner> <clueType>inhibited</clueType> the production of other cytokines.</clue>
</event>
<sentence id="S6">Therefore, the effects of <term id="T28" lex="PGE2" sem="Lipid">PGE2</term> vary depending on the mode of <term id="T29" lex="T_cell_activation" sem="Other"><term id="A3" sem="Cell_natural">T cell</term> activation</term>, and the <term id="T30" lex="IL-4" sem="Protein_molecule">IL-4</term> and <term id="T31" lex="IL-5" sem="Protein_molecule">IL-5</term> are regulated differently from <term id="T32" lex="cytokine" sem="Protein_family_or_group">other cytokines</term>.</sentence>
<event KT="Other" id="E28">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>Therefore, the effects of PGE2 vary depending on the mode of T cell <clueType>activation</clueType>, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
<comment>NER T28 MOD</comment></event>
<event KT="Other" id="E29">
<type class="Regulation"/>
<cause idref="T28"/>
<clue>Therefore, the <clueType>effects</clueType> <linkCause>of</linkCause> PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
</event>
<event KT="Analysis" id="E30">
<type class="Regulation"/>
<theme idref="E29"/>
<cause idref="E28"/>
<clue><clueKT>Therefore</clueKT>, the effects of PGE2 <clueType>vary</clueType> <linkCause>depending on</linkCause> the mode of T cell activation, and the IL-4 and IL-5 are regulated differently from other cytokines.</clue>
</event>
<event KT="Analysis" id="E31">
<type class="Regulation"/>
<theme idref="T30"/>
<cause idref="T28"/>
<clue><clueKT>Therefore</clueKT>, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> differently from other cytokines.</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E32">
<type class="Regulation"/>
<theme idref="T31"/>
<cause idref="T28"/>
<clue><clueKT>Therefore</clueKT>, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> differently from other cytokines.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Analysis" id="E33">
<type class="Regulation"/>
<theme idref="T32"/>
<cause idref="T28"/>
<clue><clueKT>Therefore</clueKT>, the effects of PGE2 vary depending on the mode of T cell activation, and the IL-4 and IL-5 are <clueType>regulated</clueType> <linkTheme>differently from</linkTheme> other cytokines.</clue>
<comment>NER T32 MOD</comment></event>
<sentence id="S7">In a <term id="T33" lex="mobility_shift_assay" sem="Other">mobility shift assay</term>, only the <term id="T34" lex="NF-kappa_B_(p50/p50)_homodimer" sem="Protein_complex">NF-kappa B (<term id="T36" lex="p50" sem="Protein_molecule">p50</term>/<term id="T37" lex="p50" sem="Protein_molecule">p50</term>) homodimer</term> was observed in a complex formed with the <term id="T38" lex="kappa_B_sequence" sem="DNA_domain_or_region">kappa B sequence</term> in <term id="A4" sem="Cell_natural">unstimulated SP-B21 cells</term>.</sentence>
<event id="E34">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="T38"/>
<clue><clueExperiment>In a mobility shift assay</clueExperiment>, only the NF-kappa B (p50/p50) homodimer was observed in a <clueType>complex formed</clueType> <linkTheme>with</linkTheme> the kappa B sequence <clueLoc>in unstimulated SP-B21 cells</clueLoc>.</clue>
<comment>NER T34,T37 MOD, T35 DEL</comment></event>
<sentence id="S8">When <term id="A6" sem="Cell_natural">cells</term> were stimulated with <term id="T39" lex="anti-CD3_mAb" sem="Protein_family_or_group">anti-CD3 mAb</term> or <term id="T40" lex="PMA" sem="Organic_compound_other">PMA</term>/<term id="T41" lex="A23187" sem="Organic_compound_other">A23187</term>, a complex formation of <term id="A5" sem="Protein_complex">NF-kappa B (<term id="T43" lex="p50" sem="Protein_molecule">p50</term>/<term id="T44" lex="p65" sem="Protein_molecule">p65</term>) heterodimer</term> with the <term id="T45" lex="kappa_B_sequence" sem="DNA_domain_or_region">kappa B sequence</term> was induced.</sentence>
<event KT="Method" id="E35">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="T39"/>
<clue>When cells were <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was induced.</clue>
<comment>NER T39,T41 MOD, T42 DEL</comment></event>
<event KT="Method" id="E36">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="T40"/>
<cause idref="T41"/>
<clue>When cells were <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was induced.</clue>
</event>
<event id="E37">
<type class="Binding"/>
<theme idref="A5"/>
<theme idref="T45"/>
<clue>When cells were stimulated with anti-CD3 mAb or PMA/A23187, a <clueType>complex formation</clueType> <linkTheme>of</linkTheme> NF-kappa B (p50/p65) heterodimer <linkTheme>with</linkTheme> the kappa B sequence was induced.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E35"/>
<clue><linkCause>When</linkCause> cells were stimulated with anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was <clueType>induced</clueType>.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E36"/>
<clue><linkCause>When</linkCause> cells were stimulated with anti-CD3 mAb or PMA/A23187, a complex formation of NF-kappa B (p50/p65) heterodimer with the kappa B sequence was <clueType>induced</clueType>.</clue>
</event>
<sentence id="S9">Interestingly, <term id="T46" lex="PGE2" sem="Lipid">PGE2</term> or <term id="T47" lex="di-butyryl_(Bt2)cAMP" sem="Nucleotide">di-butyryl (Bt2)<term id="T48" lex="cAMP" sem="Nucleotide">cAMP</term></term> abolished the binding of <term id="T49" lex="NF-kappa_B_(p50/p65)_heterodimer" sem="Protein_complex">NF-kappa B (<term id="T51" lex="p50" sem="Protein_molecule">p50</term>/<term id="T52" lex="p65" sem="Protein_molecule">p65</term>) heterodimer</term> to the <term id="T53" lex="kappa_B_sequence" sem="DNA_domain_or_region">kappa B sequence</term> in <term id="A7" sem="Cell_natural">cells</term> stimulated with <term id="T54" lex="anti-CD3_mAb" sem="Protein_molecule">anti-CD3 mAb</term> but not with <term id="T56" lex="PMA" sem="Organic_compound_other">PMA</term>/<term id="T57" lex="A23187" sem="Organic_compound_other">A23187</term>.</sentence>
<event KT="Other" id="E40">
<type class="Binding"/>
<theme idref="T49"/>
<theme idref="T53"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the <clueType>binding</clueType> <linkTheme>of</linkTheme> NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells stimulated with anti-CD3 mAb but not with PMA/A23187.</clue>
<comment>NER T46,T52,T57 MOD, T50,T55 DEL</comment></event>
<event id="E41">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T46"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated with anti-CD3 mAb</clueLoc> but not with PMA/A23187.</clue>
</event>
<event id="E42">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T47"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated with anti-CD3 mAb</clueLoc> but not with PMA/A23187.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E43">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T46"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated</clueLoc> with anti-CD3 mAb but <cluePolarity>not</cluePolarity> <clueLoc>with PMA/A23187</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E44">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T47"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP <clueType>abolished</clueType> the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence <clueLoc>in cells stimulated</clueLoc> with anti-CD3 mAb but <cluePolarity>not</cluePolarity> <clueLoc>with PMA/A23187</clueLoc>.</clue>
</event>
<event KT="Method" id="E45">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="T54"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells <clueType>stimulated</clueType> <linkCause>with</linkCause> anti-CD3 mAb but not with PMA/A23187.</clue>
</event>
<event KT="Method" id="E46">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="T56"/>
<cause idref="T57"/>
<clue>Interestingly, PGE2 or di-butyryl (Bt2)cAMP abolished the binding of NF-kappa B (p50/p65) heterodimer to the kappa B sequence in cells <clueType>stimulated</clueType> with anti-CD3 mAb but not <linkCause>with</linkCause> PMA/A23187.</clue>
</event>
<sentence id="S10">Our results suggest that the target of <term id="T58" lex="PGE2_action" sem="Other"><term id="T59" lex="PGE2" sem="Lipid">PGE2</term> action</term> is a <term id="A8" sem="Protein_family_or_group">component</term> in the <term id="A9" sem="Other">signal transduction pathway</term> leading to the activation of <term id="T60" lex="protein_kinase_C" sem="Protein_molecule">protein kinase C</term>.</sentence>
<event KT="Other" id="E47" uncertainty="probable">
<type class="Regulation"/>
<theme idref="A8"/>
<cause idref="T59"/>
<clue>Our results suggest that the <clueType>target</clueType> <linkCause>of</linkCause> PGE2 action is a component in the signal transduction pathway leading to the activation of protein kinase C.</clue>
</event>
<event KT="Other" id="E48">
<type class="Positive_regulation"/>
<theme idref="T60"/>
<clue>Our results suggest that the target of PGE2 action is a component in the signal transduction pathway leading to the <clueType>activation</clueType> <linkTheme>of</linkTheme> protein kinase C.</clue>
</event>
<event KT="Other" id="E49">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="A9"/>
<clue>Our results suggest that the target of PGE2 action is a component in the signal transduction pathway <clueType>leading</clueType> <linkTheme>to</linkTheme> the activation of protein kinase C.</clue>
</event>
<event CL="L2" KT="Analysis" id="E50">
<type class="Correlation"/>
<theme idref="A8"/>
<theme idref="E49"/>
<clue>Our results <clueKT><clueCL>suggest</clueCL></clueKT> that the target of PGE2 action is a component <clueType>in</clueType> the signal transduction pathway leading to the activation of protein kinase C.</clue>
</event>
<sentence id="S11">However, the inhibition of the <term id="T61" lex="T_cell_activation" sem="Other"><term id="A10" sem="Cell_natural">T cell</term> activation</term> signals by <term id="T62" lex="PGE2" sem="Lipid">PGE2</term> is selective.</sentence>
<event id="E51">
<type class="Physiological_process"/>
<theme idref="A10"/>
<clue>However, the inhibition of the T cell <clueType>activation signals</clueType> by PGE2 is selective.</clue>
</event>
<event id="E52">
<type class="Negative_regulation"/>
<theme idref="E51"/>
<cause idref="T62"/>
<clue>However, the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the T cell activation signals <linkCause>by</linkCause> PGE2 is selective.</clue>
</event>
<sentence id="S12"><term id="T63" lex="PGE2" sem="Lipid">PGE2</term> enhanced the complex formation with <cons id="T64" lex="(AND NF-AT_sequence AP-1_sequence CLE0_sequence)" sem="(AND DNA_domain_or_region DNA_domain_or_region DNA_domain_or_region)"><frag id="F1"><term id="A11" sem="DNA_domain_or_region">NF-AT</term></frag>, <frag id="F2"><term id="A12" sem="DNA_domain_or_region">AP-1</term></frag> and <frag id="F3"><term id="A13" sem="DNA_domain_or_region">CLE0</term></frag> <frag id="F4"><term id="A14" sem="DNA_domain_or_region">sequences</term></frag></cons> when the <term id="A15" sem="Cell_natural">cells</term> were activated by either <term id="T65" lex="anti-CD3_mAb" sem="Protein_molecule">anti-CD3 mAb</term> or <term id="T66" lex="PMA/A23187_stimulation" sem="Other"><term id="T67" lex="PMA" sem="Organic_compound_other">PMA</term>/<term id="T68" lex="A23187" sem="Organic_compound_other">A23187</term> stimulation</term>.</sentence>
<event id="E53">
<type class="Binding"/>
<theme idref="A11" idref1="A14"/>
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
<comment>NER T63,T68 MOD</comment></event>
<event id="E54">
<type class="Binding"/>
<theme idref="A12" idref1="A14"/>
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E55">
<type class="Binding"/>
<theme idref="A13" idref1="A14"/>
<clue>PGE2 enhanced the <clueType>complex formation</clueType> <linkTheme>with</linkTheme> NF-AT, AP-1 and CLE0 sequences when the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E56">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<cause idref="T63"/>
<cause idref="E59"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E61">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<cause idref="T63"/>
<cause idref="E60"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E57">
<type class="Positive_regulation"/>
<theme idref="E54"/>
<cause idref="T63"/>
<cause idref="E59"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E62">
<type class="Positive_regulation"/>
<theme idref="E54"/>
<cause idref="T63"/>
<cause idref="E60"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E58">
<type class="Positive_regulation"/>
<theme idref="E55"/>
<cause idref="T63"/>
<cause idref="E59"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E63">
<type class="Positive_regulation"/>
<theme idref="E55"/>
<cause idref="T63"/>
<cause idref="E60"/>
<clue>PGE2 <clueType>enhanced</clueType> the complex formation with NF-AT, AP-1 and CLE0 sequences <linkCause>when</linkCause> the cells were activated by either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E59">
<type class="Physiological_process"/>
<theme idref="A15"/>
<cause idref="T65"/>
<clue>PGE2 enhanced the complex formation with NF-AT, AP-1 and CLE0 sequences when the cells were <clueType>activated</clueType> <linkCause>by</linkCause> either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<event id="E60">
<type class="Physiological_process"/>
<theme idref="A15"/>
<cause idref="T67"/>
<cause idref="T68"/>
<clue>PGE2 enhanced the complex formation with NF-AT, AP-1 and CLE0 sequences when the cells were <clueType>activated</clueType> <linkCause>by</linkCause> either anti-CD3 mAb or PMA/A23187 stimulation.</clue>
</event>
<sentence id="S13">It seems therefore that <term id="T69" lex="PGE2" sem="Lipid">PGE2</term>, by elevating <term id="T70" lex="cAMP_level" sem="Other"><term id="T71" lex="cAMP" sem="Nucleotide">cAMP</term> levels</term>, interferes with the activation pathway for <term id="T72" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> but not for <term id="T73" lex="NF-AT" sem="Protein_molecule">NF-AT</term>, <term id="T74" lex="AP-1" sem="Protein_molecule">AP-1</term> or <term id="T75" lex="CLE0_binding_protein" sem="Protein_molecule">CLE0</term> <term id="A16" sem="Protein_molecule">binding protein</term>.</sentence>
<event KT="Other" id="E70">
<type class="Positive_regulation"/>
<theme idref="T72"/>
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> <linkTheme>for</linkTheme> NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
<comment>NER T75 MOD</comment></event>
<event KT="Other" id="E71">
<type class="Positive_regulation"/>
<theme idref="T73" idref1="A16"/>
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event KT="Other" id="E72">
<type class="Positive_regulation"/>
<theme idref="T74" idref1="A16"/>
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event KT="Other" id="E64">
<type class="Positive_regulation"/>
<theme idref="T75" idref1="A16"/>
<clue>It seems therefore that PGE2, by elevating cAMP levels, interferes with the <clueType>activation pathway</clueType> for NF-kappa B but not <linkTheme>for</linkTheme> NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event KT="Other" id="E65">
<type class="Positive_regulation"/>
<theme idref="T71"/>
<cause idref="T65"/>
<clue>It seems therefore that PGE2, by <clueType>elevating</clueType> cAMP <clueType>levels</clueType>, interferes with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event CL="L2" KT="Analysis" id="E66" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E61"/>
<cause idref="E65"/>
<clue>It <clueKT><clueCL>seems</clueCL> therefore</clueKT> that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but not for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E67" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E62"/>
<cause idref="E65"/>
<clue>It <clueKT><clueCL>seems</clueCL> therefore</clueKT> that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but <cluePolarity>not</cluePolarity> for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E68" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E63"/>
<cause idref="E65"/>
<clue>It <clueKT><clueCL>seems</clueCL> therefore</clueKT> that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but <cluePolarity>not</cluePolarity> for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E69" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E64"/>
<cause idref="E65"/>
<clue>It <clueKT><clueCL>seems</clueCL> therefore</clueKT> that PGE2, <linkCause>by</linkCause> elevating cAMP levels, <clueType>interferes</clueType> with the activation pathway for NF-kappa B but <cluePolarity>not</cluePolarity> for NF-AT, AP-1 or CLE0 binding protein.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
